Studies suggest that semaglutide, in either form, may reduce atherosclerotic cardiovascular risk, mainly reducing the risk of heart attack, stroke, and cardiovascular death in people with type 2 diabetes
Of note, similarly to combination therapy formulations with insulin, amylin RA needs to exhibit greater stability at pH 7.4 in order to provide the conditions to co-formulate with GLP-1 analogs [33, 41]
But theres no data showing how well it works in humans, and the long-term safety of this peptide in humans is simply unknown
How Often Should You Get Them
If you're experiencing troublesome side effects, they might keep you at your current dose for longer, or even step back to a lower dose temporarily